Washington DC… In a victory for patients’ ability to afford prescription drugs, the Trump administration has delayed for two years implementation of a provision included in a proposed…
Washington DC… In a review of health insurance plans being offered on federal and state exchanges in 2021, the HIV+Hepatitis Policy Institute is finding that many plans will not be…
Washington DC… House appropriators are proposing minimal increases for addressing the HIV epidemic in the United States by providing $90 million in increased funding in their FY2021…
Washington DC… As consumers shop for health plans during open enrollment, the HIV+Hepatitis Policy Institute is reminding people, particularly those who depend on prescription drugs, to carefully review plan policies regarding copay assistance…
Washington DC…In a setback to patients’ ability to afford prescription drugs, the Trump administration has again attacked the use of drug manufacturer copay assistance for prescription…